These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12496714)

  • 1. [The therapeutic use of D9-tetrahydrocannabinol (dronabinol) in refractory neuropathic pain].
    Clermont-Gnamien S; Atlani S; Attal N; Le Mercier F; Guirimand F; Brasseur L
    Presse Med; 2002 Nov; 31(39 Pt 1):1840-5. PubMed ID: 12496714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are oral cannabinoids safe and effective in refractory neuropathic pain?
    Attal N; Brasseur L; Guirimand D; Clermond-Gnamien S; Atlami S; Bouhassira D
    Eur J Pain; 2004 Apr; 8(2):173-7. PubMed ID: 14987627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics.
    Johnson JR; Lossignol D; Burnell-Nugent M; Fallon MT
    J Pain Symptom Manage; 2013 Aug; 46(2):207-18. PubMed ID: 23141881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.
    Karst M; Salim K; Burstein S; Conrad I; Hoy L; Schneider U
    JAMA; 2003 Oct; 290(13):1757-62. PubMed ID: 14519710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label, add-on study of tetrahydrocannabinol for chronic nonmalignant pain.
    Haroutiunian S; Rosen G; Shouval R; Davidson E
    J Pain Palliat Care Pharmacother; 2008; 22(3):213-7. PubMed ID: 19042851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study.
    de Vries M; van Rijckevorsel DCM; Vissers KCP; Wilder-Smith OHG; van Goor H;
    Clin Gastroenterol Hepatol; 2017 Jul; 15(7):1079-1086.e4. PubMed ID: 27720917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model.
    Mitchell VA; Harley J; Casey SL; Vaughan AC; Winters BL; Vaughan CW
    Neuropharmacology; 2021 May; 189():108529. PubMed ID: 33741405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study.
    Rintala DH; Fiess RN; Tan G; Holmes SA; Bruel BM
    Am J Phys Med Rehabil; 2010 Oct; 89(10):840-8. PubMed ID: 20855984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial.
    Ellis RJ; Toperoff W; Vaida F; van den Brande G; Gonzales J; Gouaux B; Bentley H; Atkinson JH
    Neuropsychopharmacology; 2009 Feb; 34(3):672-80. PubMed ID: 18688212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tetrahydrocannabinol for treatment of chronic pain].
    Elsner F; Radbruch L; Sabatowski R
    Schmerz; 2001 Jun; 15(3):200-4. PubMed ID: 11810357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy.
    Narang S; Gibson D; Wasan AD; Ross EL; Michna E; Nedeljkovic SS; Jamison RN
    J Pain; 2008 Mar; 9(3):254-64. PubMed ID: 18088560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis constituent synergy in a mouse neuropathic pain model.
    Casey SL; Atwal N; Vaughan CW
    Pain; 2017 Dec; 158(12):2452-2460. PubMed ID: 28885457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study.
    Eisenberg E; Ogintz M; Almog S
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):216-25. PubMed ID: 25118789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability.
    de Vries M; Van Rijckevorsel DC; Vissers KC; Wilder-Smith OH; Van Goor H
    Br J Clin Pharmacol; 2016 Mar; 81(3):525-37. PubMed ID: 26505163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment.
    Serpell M; Ratcliffe S; Hovorka J; Schofield M; Taylor L; Lauder H; Ehler E
    Eur J Pain; 2014 Aug; 18(7):999-1012. PubMed ID: 24420962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THC and gabapentin interactions in a mouse neuropathic pain model.
    Atwal N; Casey SL; Mitchell VA; Vaughan CW
    Neuropharmacology; 2019 Jan; 144():115-121. PubMed ID: 30312630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions.
    Naef M; Curatolo M; Petersen-Felix S; Arendt-Nielsen L; Zbinden A; Brenneisen R
    Pain; 2003 Sep; 105(1-2):79-88. PubMed ID: 14499423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief.
    Schley M; Legler A; Skopp G; Schmelz M; Konrad C; Rukwied R
    Curr Med Res Opin; 2006 Jul; 22(7):1269-76. PubMed ID: 16834825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experiences with cannabinoids in spasticity management in multiple sclerosis.
    Lorente Fernández L; Monte Boquet E; Pérez-Miralles F; Gil Gómez I; Escutia Roig M; Boscá Blasco I; Poveda Andrés JL; Casanova-Estruch B
    Neurologia; 2014 Jun; 29(5):257-60. PubMed ID: 24035293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain.
    Hoggart B; Ratcliffe S; Ehler E; Simpson KH; Hovorka J; Lejčko J; Taylor L; Lauder H; Serpell M
    J Neurol; 2015 Jan; 262(1):27-40. PubMed ID: 25270679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.